health pharma news today obesity drugs glp-1 A new oral option is now part of medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least one weight-related GLP-1 drugs transform obesity care,

18, 23 Moreover, cells derived from solid tumors that undergo loss of attachment (LOA) to the extracellular matrix (known as anoikis) display inhibition of glucose uptake and catabolism, which results in the loss of ATP, NADPH (as a result of decreased flux through the pentose phosphate pathway) and increased production of reactive oxygen species (ROS)

beta-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats

This observation hints at the plausible role of the C201-G202 dipeptide as a glutathione mimic, i.e

While many people turn to topical creams or aggressive peels, there is a growing interest in supporting skin health from the inside out using a specific molecule: glutathione

Both types of melanin showed activity against the DPPH and ABTS radicals, but the level of this protection was much lower than in the case of vitamin C

Recent studies highlight the role of microRNAs (e.g., miR-146a, miR-155) in regulating inflammation, with miR-146a suppressing NF-B activity in preclinical models (15)